Antimicrobial susceptibility and molecular characterization of community-acquired methicillin-resistant Staphylococcus aureus. 2002

Laurel S Almer, and Virginia D Shortridge, and Angela M Nilius, and Jill M Beyer, and Niru B Soni, and Mai H Bui, and Gregory G Stone, and Robert K Flamm
Infectious Diseases Research, Abbott Laboratories, Abbott Park, IL, USA. laurel.s.almer@abbott.com

Community-acquired methicillin-resistant Staphylococcus aureus (MRSA) infections are increasing. Since most published data are on nosocomial MRSA, our goal was to identify the antimicrobial susceptibility profile and resistance mechanisms of pretreatment MRSA isolates obtained from adult subjects participating in recent clinical treatment trials of community respiratory infections. Out of 465 S. aureus isolates, 43 were identified as MRSA. Antimicrobial susceptibility testing indicated susceptibility rates to: vancomycin (100%), gentamicin (86%), clindamycin (39%), quinolones (49%), and erythromycin (12%). Among our MRSA isolates, the MLS constitutive phenotype and ermA were more prevalent than the MLS inducible phenotype and ermC. No isolates had ermB or msrA. All ciprofloxacin resistant isolates had an amino acid change in GyrA and GrlA. The relatedness of our MRSA strains was assessed by ribotyping. Our results indicate that MRSA from adult subjects with community respiratory infections have similar antimicrobial susceptibility profiles and resistance mechanisms as nosocomial MRSA, and represent a genetically diverse group.

UI MeSH Term Description Entries
D008780 Methyltransferases A subclass of enzymes of the transferase class that catalyze the transfer of a methyl group from one compound to another. (Dorland, 28th ed) EC 2.1.1. Methyltransferase
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D012141 Respiratory Tract Infections Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases. Respiratory System Infections,Upper Respiratory Tract Infection,Upper Respiratory Tract Infections,Infections, Respiratory,Infections, Respiratory Tract,Infections, Upper Respiratory,Infections, Upper Respiratory Tract,Respiratory Infections,Upper Respiratory Infections,Infection, Respiratory System,Infection, Respiratory Tract,Respiratory Infection, Upper,Respiratory System Infection,Respiratory Tract Infection
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001426 Bacterial Proteins Proteins found in any species of bacterium. Bacterial Gene Products,Bacterial Gene Proteins,Gene Products, Bacterial,Bacterial Gene Product,Bacterial Gene Protein,Bacterial Protein,Gene Product, Bacterial,Gene Protein, Bacterial,Gene Proteins, Bacterial,Protein, Bacterial,Proteins, Bacterial
D013203 Staphylococcal Infections Infections with bacteria of the genus STAPHYLOCOCCUS. Infections, Staphylococcal,Staphylococcus aureus Infection,Staphylococcal Infection,Staphylococcus aureus Infections
D013211 Staphylococcus aureus Potentially pathogenic bacteria found in nasal membranes, skin, hair follicles, and perineum of warm-blooded animals. They may cause a wide range of infections and intoxications.
D016106 Methicillin Resistance Non-susceptibility of a microbe to the action of METHICILLIN, a semi-synthetic penicillin derivative. Methicillin-Resistant,Methicillin Resistant,Resistance, Methicillin

Related Publications

Laurel S Almer, and Virginia D Shortridge, and Angela M Nilius, and Jill M Beyer, and Niru B Soni, and Mai H Bui, and Gregory G Stone, and Robert K Flamm
September 1967, The New England journal of medicine,
Laurel S Almer, and Virginia D Shortridge, and Angela M Nilius, and Jill M Beyer, and Niru B Soni, and Mai H Bui, and Gregory G Stone, and Robert K Flamm
April 2004, JAMA,
Laurel S Almer, and Virginia D Shortridge, and Angela M Nilius, and Jill M Beyer, and Niru B Soni, and Mai H Bui, and Gregory G Stone, and Robert K Flamm
November 2008, Enfermedades infecciosas y microbiologia clinica,
Laurel S Almer, and Virginia D Shortridge, and Angela M Nilius, and Jill M Beyer, and Niru B Soni, and Mai H Bui, and Gregory G Stone, and Robert K Flamm
June 2005, Medecine et maladies infectieuses,
Laurel S Almer, and Virginia D Shortridge, and Angela M Nilius, and Jill M Beyer, and Niru B Soni, and Mai H Bui, and Gregory G Stone, and Robert K Flamm
August 1998, JAMA,
Laurel S Almer, and Virginia D Shortridge, and Angela M Nilius, and Jill M Beyer, and Niru B Soni, and Mai H Bui, and Gregory G Stone, and Robert K Flamm
January 2007, Journal of the American Academy of Dermatology,
Laurel S Almer, and Virginia D Shortridge, and Angela M Nilius, and Jill M Beyer, and Niru B Soni, and Mai H Bui, and Gregory G Stone, and Robert K Flamm
August 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Laurel S Almer, and Virginia D Shortridge, and Angela M Nilius, and Jill M Beyer, and Niru B Soni, and Mai H Bui, and Gregory G Stone, and Robert K Flamm
July 2007, Emerging infectious diseases,
Laurel S Almer, and Virginia D Shortridge, and Angela M Nilius, and Jill M Beyer, and Niru B Soni, and Mai H Bui, and Gregory G Stone, and Robert K Flamm
September 2015, The Indian journal of medical research,
Laurel S Almer, and Virginia D Shortridge, and Angela M Nilius, and Jill M Beyer, and Niru B Soni, and Mai H Bui, and Gregory G Stone, and Robert K Flamm
June 2002, Emerging infectious diseases,
Copied contents to your clipboard!